New Zealand to improve ethics committee approval process for pharma trials
This article was originally published in SRA
Executive Summary
The government of New Zealand has pledged to improve the country's clinical trials environment and has outlined how it plans to streamline and simplify the ethics committee approval process over the next 10 months1,2.